IPO registrations (S-1, F-1) · Registrants
Esperion Therapeutics, Inc.
- SEC CIK
- 1434868 · filings on EDGAR ↗
- Former names
- HDL THERAPEUTICS INC (2008–2008)
- Registration
- Form S-1, first filed 2013-05-14, last 2013-06-12; 1 initial registration, 2 amendments
- Outcome
- Final prospectus filed 2013-06-26; declared effective 2013-06-25
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 3891 RANCHERO DRIVE, SUITE 150, Ann Arbor, MI 48108
- EDGAR entity type
- operating
- Insiders and CEO pay
- Esperion Therapeutics, Inc. on the corporate pages
Offering terms
- Proposed price range
- $13.00–$15.00 per share (S-1/A filed 2013-06-12)
- Final price
- $14.00 per share, within the range (424B4 filed 2013-06-26, an initial public offering)
- Shares sold
- 5,000,000
- Gross proceeds
- $70,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol ESPR
- Lead underwriters
- Credit Suisse; Citigroup
- Syndicate
- JMP Securities; Stifel
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: Esperion Therapeutics, Inc. Fuzzy (name and state)
- Business registration: ESPERION THERAPEUTICS, Inc. Fuzzy (name and state)
- Business registration: ESPERION THERAPEUTICS, INC. Fuzzy (name and state)
- Business registration: ESPERION THERAPEUTICS, INC. Fuzzy (name and state)
- Business registration: ESPERION THERAPEUTICS, INC. Fuzzy (name and state)
- Business registration: ESPERION THERAPEUTICS, INC. Fuzzy (name and state)
- Business registration: ESPERION THERAPEUTICS, INC. Fuzzy (name and state)
- Business registration: ESPERION THERAPEUTICS, INC. Fuzzy (name and state)
- Business registration: ESPERION THERAPEUTICS, INC. Fuzzy (name and state)
- Business registration: ESPERION THERAPEUTICS, INC. Fuzzy (name and state)
- Federal award recipient: ESPERION THERAPEUTICS, INC. Fuzzy (name and state)
- Form D issuer: Esperion Therapeutics, Inc. EXACT (CIK (EXACT))
- SEC filer: Esperion Therapeutics, Inc. EXACT (CIK (EXACT))
Filings 8
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2013-05-14 | S-1 | S-1 (registration) | Esperion Therapeutics, Inc. | 0001047469-13-006083 ↗ |
| 2013-06-07 | S-1/A | S-1/A (amendment) | Esperion Therapeutics, Inc. | 0001047469-13-006837 ↗ |
| 2013-06-12 | S-1/A | S-1/A (amendment) | Esperion Therapeutics, Inc. | 0001047469-13-006896 ↗ |
| 2013-06-25 | S-1MEF | S-1MEF (added securities) | Esperion Therapeutics, Inc. | 0001104659-13-051361 ↗ |
| 2013-06-25 | EFFECT | EFFECT (declared effective) | Esperion Therapeutics, Inc. | 9999999995-13-001908 ↗ |
| 2013-06-26 | 424B4 | 424B4 (final prospectus) | Esperion Therapeutics, Inc. | 0001047469-13-007205 ↗ |
| 2014-07-09 | EFFECT | EFFECT (declared effective) | Esperion Therapeutics, Inc. | 9999999995-14-002097 ↗ |
| 2014-12-31 | EFFECT | EFFECT (declared effective) | Esperion Therapeutics, Inc. | 9999999995-15-000015 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2013-06-12 | S-1/A | registration statement | $13.00–$15.00 | 4,500,000 | - | Nasdaq ESPR | 4 | primary document; range, shares headline, cover names 4 | document ↗ | |
| 2013-06-26 | 424B4 | final prospectus | $14.00 | 5,000,000 | $70,000,000 | Nasdaq ESPR | 4 | primary document; price sentence, shares headline, proceeds table, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Aisling Capital II LP | TenPercentOwner | 3 | 2013–2015 | ||
| AISLING CAPITAL PARTNERS LLC | TenPercentOwner | 3 | 2013–2015 | ||
| AISLING CAPITAL PARTNERS, LP | TenPercentOwner | 3 | 2013–2015 | ||
| Alta Partners Management VIII, LLC | TenPercentOwner | 3 | 2013–2014 | ||
| Alta Partners VIII, L.P. | TenPercentOwner | 4 | 2013–2015 | ||
| BLAIR JAMES C | TenPercentOwner | 4 | 2013–2015 | ||
| CHAMPSI FARAH | TenPercentOwner | 3 | 2013–2014 | ||
| DOMAIN ASSOCIATES | TenPercentOwner | 1 | 2013 | ||
| DOMAIN PARTERS VII L P | TenPercentOwner | 4 | 2013–2015 | ||
| DOVEY BRIAN H | TenPercentOwner | 4 | 2013–2015 | ||
| DP VII ASSOCIATES LP | TenPercentOwner | 2 | 2013 | ||
| ELMS STEVE | TenPercentOwner | 3 | 2013–2015 | ||
| ENRIGHT PATRICK G | Director; Director,TenPercentOwner | 8 | 2013–2015 | ||
| GOLDSTEIN DOV A MD | Director | 13 | 2013–2018 | ||
| Halak Brian K | TenPercentOwner | 4 | 2013–2015 | ||
| Ignelzi Troy A. | Officer | Vice President | 1 | 2013 | |
| JANNEY DANIEL | Director; Director,TenPercentOwner | 13 | 2013–2021 | ||
| Kamdar Kim P. | TenPercentOwner | 1 | 2013 | ||
| LANGE LOUIS G | Director | 2 | 2013 | ||
| Longitude Capital Associates, L.P. | TenPercentOwner | 5 | 2013–2014 | ||
| Longitude Capital Partners, LLC | TenPercentOwner | 5 | 2013–2014 | ||
| Longitude Venture Partners L.P. | TenPercentOwner | 5 | 2013–2014 | ||
| MAYLEBEN TIMOTHY M | Director,Officer | Pres & Chief Executive Officer; President and CEO; President & CEO | 28 | 2013–2021 | |
| NEWTON ROGER S | Director; Director,Officer | Executive Chairman & C.S.O.; Executive Chairman & CSO; Executive Chairman, CSO | 15 | 2013–2019 | |
| NOHRA GUY P | TenPercentOwner | 3 | 2013–2014 | ||
| Purcell Dennis J | TenPercentOwner | 3 | 2013–2015 | ||
| Rosenberg Noah L. | Officer | Chief Medical Officer | 2 | 2013 | |
| SCHIFF ANDREW N | TenPercentOwner | 3 | 2013–2015 | ||
| SCHOEMAKER KATHLEEN K | TenPercentOwner | 4 | 2013–2015 | ||
| Tammenoms Bakker Juliet | TenPercentOwner | 5 | 2013–2014 | ||
| TREU JESSE I | TenPercentOwner | 4 | 2013–2015 | ||
| VITULLO NICOLE | Director; Director,TenPercentOwner | 20 | 2013–2025 | ||
| GOTTO ANTONIO M JR MD D PHIL | Director | 12 | 2014–2024 | ||
| MCGOVERN MARK E | Director | 11 | 2014–2021 | ||
| OMENN GILBERT S | Director | 8 | 2014–2017 | ||
| Lalwani Narendra D. | Officer | Chief Operating Officer | 10 | 2014–2018 | |
| Braunstein Scott | Director | 6 | 2015–2019 | ||
| McGowan Mary | Officer | Chief Medical Officer | 5 | 2015–2017 | |
| Shah Nimesh | TenPercentOwner | 1 | 2015 | ||
| Bartram Richard | Officer | Chief Financial Officer | 9 | 2017–2022 | |
| Berkowitz Jeffrey | Director | 7 | 2018–2022 | ||
| BB BIOTECH AG | TenPercentOwner | 20 | 2018–2021 | ||
| BIOTECH TARGET N V | TenPercentOwner | 20 | 2018–2021 | ||
| Shepard Jay | Director | 11 | 2018–2026 | ||
| Boxer Asset Management Inc. | TenPercentOwner | 2 | 2018 | ||
| Boxer Capital, LLC | TenPercentOwner | 2 | 2018 | ||
| Braslyn Ltd. | TenPercentOwner | 1 | 2018 | ||
| LEWIS JOSEPH | TenPercentOwner | 2 | 2018 | ||
| Tuesday Thirteen Inc. | TenPercentOwner | 1 | 2018 | ||
| Glickman Mark A | Officer | Chief Commercial Officer | 2 | 2018–2020 | |
| Woody Tracy M | Director | 8 | 2019–2025 | ||
| Hall Ashley | Officer | Chief Development Officer | 2 | 2020–2021 | |
| Fuhrman Alan | Director | 7 | 2020–2024 | ||
| Koenig Sheldon L. | Director,Officer; Officer | Chief Operating Officer; President and CEO | 26 | 2020–2026 | |
| Foody Joanne M. | Officer | Chief Medical Officer | 16 | 2021–2024 | |
| Fischer Seth H. Z. | Director | 8 | 2021–2026 | ||
| Looker Benjamin | Officer | Chief Legal Officer; General Counsel | 18 | 2022–2026 | |
| Warren Eric | Officer | Chief Commercial Officer | 33 | 2022–2025 | |
| ROCAMBOLI STEPHEN | Director | 6 | 2022–2025 | ||
| CARROLL J MARTIN | Director | 9 | 2022–2026 | ||
| Halladay Benjamin | Officer | Chief Financial Officer | 18 | 2022–2026 | |
| Hoffman Robert E. | Director | 5 | 2025–2026 | ||
| THOMPSON JOHN CRAIG | Director | 4 | 2025–2026 | ||
| Harlow John B. Jr. | Officer | Chief Commercial Officer | 3 | 2025–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2014-07-15 | Esperion Therapeutics, Inc. | Pharmaceuticals | Indefinite | $0 | 1 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | Esperion Therapeutics, Inc. | MI | State business registries | name and state |
| Business registration | ESPERION THERAPEUTICS, Inc. | MI | State business registries | name and state |
| Business registration | ESPERION THERAPEUTICS, INC. | MI | State business registries | name and state |
| Business registration | ESPERION THERAPEUTICS, INC. | MI | State business registries | name and state |
| Business registration | ESPERION THERAPEUTICS, INC. | MI | State business registries | name and state |
| Business registration | ESPERION THERAPEUTICS, INC. | MI | State business registries | name and state |
| Business registration | ESPERION THERAPEUTICS, INC. | MI | State business registries | name and state |
| Business registration | ESPERION THERAPEUTICS, INC. | MI | State business registries | name and state |
| Business registration | ESPERION THERAPEUTICS, INC. | MI | State business registries | name and state |
| Business registration | ESPERION THERAPEUTICS, INC. | MI | State business registries | name and state |
| Federal award recipient | ESPERION THERAPEUTICS, INC. | MI | Federal spending (USAspending) | name and state |
| Form D issuer | Esperion Therapeutics, Inc. | MI | Form D private offerings | CIK (EXACT) |
| Paying company | Esperion Therapeutics, Inc. | MI | Open Payments (drug and device company payments) | name and state |
| Patent assignee | Esperion Therapeutics, Inc. | MI | Patents (USPTO) | name and state |
| SEC filer | Esperion Therapeutics, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Esperion Therapeutics, Inc. | MI | Trademarks (USPTO) | name and state |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, MI first:
- ROCKWELL MEDICAL, INC. MI
- ESPERION THERAPEUTICS INC/MI MI
- QUATRX PHARMACEUTICALS Co MI
- One World Products, Inc. MI
- Zomedica Corp. MI
- Cirius Therapeutics, Inc. MI
- MorphoSys AG 2M
- Affimed N.V. 2M
- InflaRx N.V. 2M
- Biofrontera AG 2M
In other datasets, the same topic (Health) in MI:
- Nonprofit: 60-MILE MEN (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health